The Claim

Daily treatment with 20 mg of rosuvastatin reduces the risk of major cardiovascular events by 44% compared to placebo over a median follow-up of 2 years in middle-aged and older adults with elevated C-reactive protein and low LDL cholesterol.

Source: Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
59score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In middle-aged and older adults with high inflammation and low LDL cholesterol, taking 20 mg of rosuvastatin daily for two years reduces the risk of heart attacks, strokes, or other major cardiovascular events by 44% compared to taking a placebo.

See the scientific wording

In middle-aged and older adults with elevated C-reactive protein and low LDL cholesterol, daily treatment with 20 mg of rosuvastatin reduces the risk of major cardiovascular events by 44% compared to placebo over a median follow-up of 2 years, demonstrating that statin therapy provides significant cardiovascular protection even in individuals without prior cardiovascular disease or diabetes.

Why this might work

Rosuvastatin blocks the liver's production of cholesterol, causing liver cells to pull more cholesterol out of the blood. This lowers the amount of cholesterol circulating in the bloodstream, which reduces the buildup of fatty deposits in artery walls. These deposits become less likely to crack or burst, preventing blood clots that cause heart attacks and strokes.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50 mg/dl with rosuvastatin. The JUPITER trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

    For healthy people over 50 with inflammation but normal cholesterol, taking a daily rosuvastatin pill cut their risk of heart attacks and strokes by nearly half over two years, and it didn’t cause more side effects.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.